About Us

About us

Precision Medicine for Every Body.

The Baltic Association of Precision Medicine (BAPM) is a nonprofit organisation dedicated to reducing adverse drug events by advancing the field of Precision Medicine. BAPM drives innovation through research, education, collaboration, and communication, fostering medical breakthroughs that deliver more effective and personalised care. Through its initiatives and services, BAPM promotes the rapid dissemination of emerging scientific discoveries to researchers, clinicians, and stakeholders committed to delivering the right treatment to the right patient, at the right dose, via the right route, at the right time. BAPM supports science education and workforce training to enable precision medical care, tailored to an individual’s genomic makeup, environment, and lifestyle. This approach enhances disease prevention and treatment by adopting more targeted and effective strategies. Additionally, BAPM facilitates meaningful collaboration among precision medicine's four key stakeholders: Patients, Providers, Public Health Planners (Government), and Payers. By fostering this multi-stakeholder dialogue, AAPM works toward achieving the shared goal of improved health outcomes at lower costs.

Mission Statement

Our mission is to advance the science and practice of Precision Medicine by promoting research, education, policy development, and collaborative partnerships that enable the delivery of personalised healthcare tailored to each individual’s genetic, environmental, and lifestyle profile. We are committed to reducing adverse drug reactions, improving treatment outcomes, and fostering equitable access to innovative therapies through data-driven, patient-centred solutions.

2030

Genomics for disease

Genomics is routine. Genetic causes and targeted therapies are discovered for many “common” diseases. Microbiome measures are routinely included.

2030

Genomics for healthy individuals

The guide for personalised prevention and lifestyle choices.

2030

Pharmacogenomics (PGx)

Genome-aware EHRs make PGx easy and automatically update rules from central guidelines. New PGx associations discovered from clinical data.

2030

Size of cohorts used in analysis

>100M using cloud-based federated analyses facilitated by common standards. Cost of a whole genome $ 20.00.